Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy.
A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor and cesarean delivery, is presented.
Pamnani
Anup
A
Department of Anesthesiology, New York Presbyterian Hospital, Weill-Cornell Medical Center, New York, NY 10065, USA.
Rosenstein
Megan
M
Darwich
Alaeldin
A
Wolfson
Alexander
A
D000328:Adult; D000767:Anesthesia, Epidural / Q000379:methods*; D020152:Antithrombin III Deficiency / Q000150:complications / Q000188:drug therapy*; D000991:Antithrombins / Q000008:administration & dosage*; D002585:Cesarean Section / Q000379:methods; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011994:Recombinant Proteins
D000991:Antithrombins; D011994:Recombinant Proteins